Telmiduce H Tablet is a pharmaceutical product that combines Hydrochlorothiazide and Telmisartan to treat hypertension and reduce the risk of cardiovascular events.


Telmiduce H Tablet is a pharmaceutical product that combines Hydrochlorothiazide and Telmisartan as its active ingredients. This tablet is commonly prescribed to treat various ailments related to hypertension and fluid retention.

Hydrochlorothiazide is a diuretic that helps in eliminating excess salt and water from the body. It works by increasing urine production, which in turn reduces fluid buildup and helps lower blood pressure. Telmisartan, on the other hand, belongs to a class of drugs known as angiotensin II receptor blockers. It acts by blocking the action of angiotensin II, a hormone that constricts blood vessels, thereby lowering blood pressure.

Telmiduce H Tablet is primarily used in the treatment of hypertension (high blood pressure) and edema (fluid retention). It serves as an effective combination therapy to manage high blood pressure by relaxing and dilating blood vessels, ultimately improving blood flow and reducing the workload on the heart. This medication may help prevent heart attacks, strokes, and kidney problems associated with hypertension.

The tablet should be taken orally, as directed by a healthcare professional. It is usually recommended to start with a low dose and gradually increase if necessary. Regular monitoring of blood pressure is essential throughout the course of treatment to ensure its effectiveness.

In conclusion, Telmiduce H Tablet is a powerful and widely used medication for managing hypertension and fluid retention. With its combination of Hydrochlorothiazide and Telmisartan, it helps regulate blood pressure by promoting diuresis and relaxing blood vessels. By effectively lowering blood pressure, this medicine plays a crucial role in preventing cardiovascular events and maintaining renal health. As with any medication, it is important to consult a healthcare professional for proper dosage and usage guidance.

Additional information

Marketed by


Dosage form




Therapeutic use


You may also like…